Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612386 · ClinicalTrials.gov registry record · NA
Planning Message Recommending Same Time/Location as Last Vaccine
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 520,000
- Enrollment target
NCT05612386: Completed NA study, sponsored by University of Pennsylvania.
NCT05612386 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 520,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05612386, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 520,000 participants
- Enrollment target
Study Summary
This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message suggesting the same day of the week, at the same time of day, and at the same pharmacy location as their last vaccination and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination by suggesting patients receive a shot on the same day of the week, at the same time of day, and at the same pharmacy location as their last vaccination will produce more vaccinations than otherwise identical messages.
Interventions
- BEHAVIORAL COVID Booster text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520,000 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2023-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05612386
The ClinicalTrials.gov registry entry for NCT05612386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 520,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID Booster text messages is the first listed.
NCT05612386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05612386 about?
NCT05612386 is a clinical study titled "Planning Message Recommending Same Time/Location as Last Vaccine". This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message suggesting the same day of the week, at the same time of day, and at the same p...
What is the current status of trial NCT05612386?
This trial is currently completed. It is a NA study. The enrollment target is 520,000 participants. The study started on 2022-11-03. Estimated completion is 2023-02-06.
What interventions are being tested in trial NCT05612386?
The interventions under investigation include: COVID Booster text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05612386?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.